Ronald Martell

Ronald A. Martell was the founder of Achieve Life Science, Inc. founded in 2015, where the title held was Chief Executive Officer from 2015 to 2017.
Mr. Martell was the founder of Orca Biosystems, Inc. founded in 2016, where the title held was Executive Chairman from 2016 to 2019.
Mr. Martell was the founder of Indapta Therapeutics, Inc. founded in 2017, where the title held was Executive Chairman from 2017 to 2022.
Mr. Martell is also the founder of Cetya Therapeutics, Inc.,Encellin, Inc...
Mr. Martell is currently an Independent Director at MorphImmune, Inc. starting in 2022.
Former positions include Chairman & Chief Executive Officer at Poniard Pharmaceuticals, Inc. in 2012; President, Chief Executive Officer & Director at Sevion Therapeutics, Inc. from 2014 to 2015; President, Chief Executive Officer & Director at NeurogesX, Inc. from 2012 to 2013; President, Chief Executive Officer & Director at Nuvelution Pharma, Inc. from 2019 to 2021; President, Chief Executive Officer & Director at Jasper Therapeutics, Inc. from 2022 to 2026; Executive Chairman at Humanigen, Inc. in 2015; Executive Chairman at Kalobios Pharmaceuticals, Inc. in 2015; Independent Director at Plus Therapeutics, Inc. from 2016 to 2019; Group Manager-Oncology Products at Genentech, Inc. from 1988 to 1998; Senior Vice President-Commercial Operations at ImClone LLC from 1998 to 2006.